{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:45:33Z","timestamp":1788417933132,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","award":["0320190260"],"award-info":[{"award-number":["0320190260"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ygyno.2020.02.002","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T05:05:28Z","timestamp":1581051928000},"page":"542-548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Association between pelvic inflammatory disease and risk of ovarian cancer: An updated meta-analysis"],"prefix":"10.1016","volume":"157","author":[{"given":"Jinlan","family":"Piao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Ji","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8017-3176","authenticated-orcid":false,"given":"Maria","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2020.02.002_bb0005","first-page":"101","article-title":"Incidence and mortality of female breast cancer in the Asia-Pacific region","volume":"11","author":"Youlden","year":"2014","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.ygyno.2020.02.002_bb0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of ovarian cancer: a review","volume":"14","author":"Reid","year":"2017","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.ygyno.2020.02.002_bb0015","series-title":"Genital Powder Use and Risk of Ovarian Cancer: A Pooled Analysis of 8,525 Cases and 9,859 Controls. Cancer Prevention Research (Philadelphia, Pa)","first-page":"811","volume":"6","author":"Terry","year":"2013"},{"key":"10.1016\/j.ygyno.2020.02.002_bb0020","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00404-013-2784-1","article-title":"Ovarian epithelial tumors and reproductive factors: a systematic review","volume":"287","author":"Schuler","year":"2013","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.ygyno.2020.02.002_bb0025","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1470-2045(11)70404-1","article-title":"Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies","volume":"13","author":"Pearce","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2020.02.002_bb0030","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/jnci\/91.17.1459","article-title":"Possible role of ovarian epithelial inflammation in ovarian cancer","volume":"91","author":"Ness","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2020.02.002_bb0035","doi-asserted-by":"crossref","first-page":"293","DOI":"10.17772\/gp\/1579","article-title":"Inflammation and ovarian cancer-current views","volume":"84","author":"Kisielewski","year":"2013","journal-title":"Ginekol Pol."},{"key":"10.1016\/j.ygyno.2020.02.002_bb0040","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.4161\/cc.8.19.9590","article-title":"Inflammation: a hidden path to breaking the spell of ovarian cancer","volume":"8","author":"Shan","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ygyno.2020.02.002_bb0045","first-page":"E421","article-title":"Pelvic inflammatory disease and risk of invasive ovarian cancer and borderline ovarian tumors: a pooled analysis of 13 case-control studies","volume":"131","author":"Rasmussen","year":"2015","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.ygyno.2020.02.002_bb0050","first-page":"415","article-title":"Pelvic inflammatory disease and the risk of ovarian cancer: a meta-analysis","volume":"28","author":"Zhou","year":"2017","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ygyno.2020.02.002_bb0055","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra1411426","article-title":"Pelvic inflammatory disease","volume":"372","author":"Brunham","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2020.02.002_bb0060","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00000478-199002000-00008","article-title":"Endometrial histopathology in patients with culture-proved upper genital tract infection and laparoscopically diagnosed acute salpingitis","volume":"14","author":"Kiviat","year":"1990","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2020.02.002_bb0065","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/01.olq.0000175375.60973.cb","article-title":"Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985\u20132001","volume":"32","author":"Sutton","year":"2005","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.ygyno.2020.02.002_bb0070","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1007\/s00261-014-0158-1","article-title":"CT findings of acute pelvic inflammatory disease","volume":"39","author":"Lee","year":"2014","journal-title":"Abdom. Imaging"},{"key":"10.1016\/j.ygyno.2020.02.002_bb0075","first-page":"447","article-title":"Pelvic inflammatory disease and the risk of epithelial ovarian cancer","volume":"4","author":"Risch","year":"1995","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2020.02.002_bb0080","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ygyno.2016.08.318","article-title":"Increased risk of borderline ovarian tumors in women with a history of pelvic inflammatory disease: a nationwide population-based cohort study","volume":"143","author":"Rasmussen","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.02.002_bb0085","first-page":"667","article-title":"Pelvic inflammatory disease and risk of ovarian cancer","volume":"5","author":"Parazzini","year":"1996","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2020.02.002_bb0090","doi-asserted-by":"crossref","first-page":"293","DOI":"10.17772\/gp\/1579","article-title":"Inflammation and ovarian cancer\u2014current views","volume":"84","author":"Kisielewski","year":"2013","journal-title":"Ginekol. Pol."},{"key":"10.1016\/j.ygyno.2020.02.002_bb0095","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S1470-2045(11)70165-6","article-title":"Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study","volume":"12","author":"Lin","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2020.02.002_bb0100","first-page":"3670","article-title":"Population-based case-control study of ovarian cancer in Shanghai","volume":"49","author":"Shu","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2020.02.002_bb0105","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S1470-2045(11)70353-9","article-title":"Pelvic inflammatory disease and ovarian cancer reply","volume":"12","author":"Lin","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2020.02.002_bb0110","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1186\/s12885-016-2857-1","article-title":"Risk of uterine, ovarian and breast cancer following pelvic inflammatory disease: a nationwide population-based retrospective cohort study","volume":"16","author":"Shen","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2020.02.002_bb0115","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1158\/1055-9965.EPI-16-0459","article-title":"Is pelvic inflammatory disease a risk factor for ovarian cancer?","volume":"26","author":"Rasmussen","year":"2017","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2020.02.002_bb0120","first-page":"1459","article-title":"Pelvic inflammatory disease and risk of invasive ovarian cancer and ovarian borderline tumors","volume":"24","author":"Rasmussen","year":"2013","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ygyno.2020.02.002_bb0125","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00001648-200003000-00006","article-title":"Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer","volume":"11","author":"Ness","year":"2000","journal-title":"Epidemiology"},{"key":"10.1016\/j.ygyno.2020.02.002_bb0130","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ijc.23017","article-title":"Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer","volume":"122","author":"Merritt","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2020.02.002_bb0135","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1097\/IGC.0000000000000235","article-title":"Pelvic inflammation and the pathogenesis of ovarian cancer: a cohort study","volume":"24","author":"McAlpine","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2020.02.002_bb0140","first-page":"1081","article-title":"Benign gynecologic conditions are associated with ovarian cancer risk in African-American women: a case-control study","volume":"29","author":"Park","year":"2018","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ygyno.2020.02.002_bb0145","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/s41416-019-0422-9","article-title":"Sexually transmitted infections and risk of epithelial ovarian cancer: results from the nurses\u2019 health studies","volume":"120","author":"Fortner","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2020.02.002_bb0150","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/ijc.24091","article-title":"Markers of inflammation and risk of ovarian cancer in Los Angeles County","volume":"124","author":"Wu","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2020.02.002_bb0155","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ygyno.2012.10.023","article-title":"In vitro fertilization, endometriosis, nulliparity and ovarian cancer risk","volume":"128","author":"Stewart","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.02.002_bb0160","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/aje\/kww161","article-title":"Pelvic inflammatory disease and the risk of ovarian cancer and borderline ovarian tumors: a pooled analysis of 13 case-control studies","volume":"185","author":"Rasmussen","year":"2017","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ygyno.2020.02.002_bb0165","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.canep.2018.05.011","article-title":"Risk of high-grade serous ovarian cancer associated with pelvic inflammatory disease, parity and breast cancer","volume":"55","author":"Stewart","year":"2018","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.ygyno.2020.02.002_bb0170","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1002\/ijc.23173","article-title":"Inflammation and cancer: an ancient link with novel potentials","volume":"121","author":"Hussain","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2020.02.002_bb0175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1574-695X.2000.tb01410.x","article-title":"Mycoplasmal infections alter gene expression in cultured human prostatic and cervical epithelial cells","volume":"27","author":"Zhang","year":"2000","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.ygyno.2020.02.002_bb0180","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1471-2180-9-139","article-title":"Intracellular Mycoplasma genitalium infection of human vaginal and cervical epithelial cells elicits distinct patterns of inflammatory cytokine secretion and provides a possible survival niche against macrophage-mediated killing","volume":"9","author":"McGowin","year":"2009","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.ygyno.2020.02.002_bb0185","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2020.02.002_bb0190","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1158\/1541-7786.MCR-05-0261","article-title":"Inflammation, a key event in cancer development","volume":"4","author":"Lu","year":"2006","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ygyno.2020.02.002_bb0195","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13027-017-0134-9","article-title":"The potential role of infectious agents and pelvic inflammatory disease in ovarian carcinogenesis","volume":"12","author":"Ingerslev","year":"2017","journal-title":"Infect. Agent Cancer"},{"key":"10.1016\/j.ygyno.2020.02.002_bb0200","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/aogs.12254","article-title":"Prevalence of human papillomavirus in epithelial ovarian cancer tissue. A meta-analysis of observational studies","volume":"93","author":"Svahn","year":"2014","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.ygyno.2020.02.002_bb0205","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0959-8049(95)00531-5","article-title":"Role of oxygen free radicals in cancer development","volume":"32a","author":"Dreher","year":"1996","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2020.02.002_bb0210","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1158\/1055-9965.EPI-19-0375","article-title":"Douching, talc use, and risk for ovarian cancer and conditions related to genital tract inflammation","volume":"28","author":"Garbriel","year":"2019","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2020.02.002_bb0215","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/his.12046","article-title":"Fallopian tube precursors of ovarian low- and high-grade serous neoplasms","volume":"62","author":"Vang","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.ygyno.2020.02.002_bb0220","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0140-6736(97)08064-1","article-title":"Over-the-counter analgesics and risk of ovarian cancer","volume":"351","author":"Cramer","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2020.02.002_bb0225","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ijc.2910550313","article-title":"Hair dyes, analgesics, tranquilizers and perineal talc application as risk factors for ovarian cancer","volume":"55","author":"Tzonou","year":"1993","journal-title":"Int. J. Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820300974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820300974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:50:17Z","timestamp":1758772217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825820300974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0090825820300974"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.02.002","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between pelvic inflammatory disease and risk of ovarian cancer: An updated meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}